nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Fenofibrate—coronary artery disease	0.0629	0.117	CbGbCtD
Trametinib—CYP2C8—Gemfibrozil—coronary artery disease	0.0503	0.0932	CbGbCtD
Trametinib—CYP2C8—Clopidogrel—coronary artery disease	0.0436	0.0808	CbGbCtD
Trametinib—CYP2C8—Pitavastatin—coronary artery disease	0.0381	0.0706	CbGbCtD
Trametinib—CYP3A4—Ticagrelor—coronary artery disease	0.0286	0.053	CbGbCtD
Trametinib—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0274	0.0507	CbGbCtD
Trametinib—CYP2C8—Simvastatin—coronary artery disease	0.0261	0.0484	CbGbCtD
Trametinib—CYP2C8—Pravastatin—coronary artery disease	0.0256	0.0474	CbGbCtD
Trametinib—CYP2C8—Lovastatin—coronary artery disease	0.0256	0.0474	CbGbCtD
Trametinib—CYP3A4—Fenofibrate—coronary artery disease	0.0255	0.0473	CbGbCtD
Trametinib—CYP2C8—Atorvastatin—coronary artery disease	0.0233	0.0431	CbGbCtD
Trametinib—CYP2C8—Losartan—coronary artery disease	0.0213	0.0395	CbGbCtD
Trametinib—CYP3A4—Gemfibrozil—coronary artery disease	0.0204	0.0378	CbGbCtD
Trametinib—CYP3A4—Clopidogrel—coronary artery disease	0.0177	0.0328	CbGbCtD
Trametinib—CYP3A4—Eplerenone—coronary artery disease	0.0164	0.0305	CbGbCtD
Trametinib—CYP3A4—Enalapril—coronary artery disease	0.0146	0.0271	CbGbCtD
Trametinib—CYP3A4—Ezetimibe—coronary artery disease	0.0114	0.0211	CbGbCtD
Trametinib—CYP3A4—Rosuvastatin—coronary artery disease	0.0114	0.0211	CbGbCtD
Trametinib—CYP3A4—Simvastatin—coronary artery disease	0.0106	0.0196	CbGbCtD
Trametinib—CYP3A4—Pravastatin—coronary artery disease	0.0104	0.0192	CbGbCtD
Trametinib—CYP3A4—Lovastatin—coronary artery disease	0.0104	0.0192	CbGbCtD
Trametinib—CYP3A4—Atorvastatin—coronary artery disease	0.00944	0.0175	CbGbCtD
Trametinib—CYP3A4—Losartan—coronary artery disease	0.00863	0.016	CbGbCtD
Trametinib—MAP2K2—cardiac ventricle—coronary artery disease	0.0017	0.152	CbGeAlD
Trametinib—MAP2K2—myocardium—coronary artery disease	0.0016	0.143	CbGeAlD
Trametinib—MAP2K1—heart—coronary artery disease	0.00127	0.114	CbGeAlD
Trametinib—MAP2K1—cardiovascular system—coronary artery disease	0.0012	0.107	CbGeAlD
Trametinib—MAP2K2—heart—coronary artery disease	0.00112	0.1	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—coronary artery disease	0.00105	0.0945	CbGeAlD
Trametinib—MAP2K2—cardiac atrium—coronary artery disease	0.000955	0.0856	CbGeAlD
Trametinib—MAP2K1—blood—coronary artery disease	0.000947	0.0848	CbGeAlD
Trametinib—MAP2K2—blood—coronary artery disease	0.000833	0.0747	CbGeAlD
Trametinib—CYP2C8—blood—coronary artery disease	0.000289	0.0259	CbGeAlD
Trametinib—CYP3A4—blood—coronary artery disease	0.000195	0.0175	CbGeAlD
Trametinib—Fatigue—Perindopril—coronary artery disease	9.99e-05	0.000444	CcSEcCtD
Trametinib—Cough—Ramipril—coronary artery disease	9.97e-05	0.000443	CcSEcCtD
Trametinib—Muscle spasms—Lisinopril—coronary artery disease	9.96e-05	0.000443	CcSEcCtD
Trametinib—Constipation—Perindopril—coronary artery disease	9.91e-05	0.000441	CcSEcCtD
Trametinib—Vomiting—Fenofibrate—coronary artery disease	9.91e-05	0.00044	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Losartan—coronary artery disease	9.91e-05	0.00044	CcSEcCtD
Trametinib—Abdominal pain—Trandolapril—coronary artery disease	9.88e-05	0.000439	CcSEcCtD
Trametinib—Body temperature increased—Trandolapril—coronary artery disease	9.88e-05	0.000439	CcSEcCtD
Trametinib—Dizziness—Ezetimibe—coronary artery disease	9.87e-05	0.000439	CcSEcCtD
Trametinib—Abdominal pain—Enalapril—coronary artery disease	9.84e-05	0.000437	CcSEcCtD
Trametinib—Body temperature increased—Enalapril—coronary artery disease	9.84e-05	0.000437	CcSEcCtD
Trametinib—Insomnia—Losartan—coronary artery disease	9.83e-05	0.000437	CcSEcCtD
Trametinib—Rash—Fenofibrate—coronary artery disease	9.83e-05	0.000437	CcSEcCtD
Trametinib—Dermatitis—Fenofibrate—coronary artery disease	9.82e-05	0.000436	CcSEcCtD
Trametinib—Decreased appetite—Furosemide—coronary artery disease	9.8e-05	0.000435	CcSEcCtD
Trametinib—Headache—Fenofibrate—coronary artery disease	9.76e-05	0.000434	CcSEcCtD
Trametinib—Vision blurred—Lisinopril—coronary artery disease	9.76e-05	0.000434	CcSEcCtD
Trametinib—Gastrointestinal pain—Captopril—coronary artery disease	9.76e-05	0.000434	CcSEcCtD
Trametinib—Cough—Timolol—coronary artery disease	9.75e-05	0.000433	CcSEcCtD
Trametinib—Vomiting—Clopidogrel—coronary artery disease	9.74e-05	0.000433	CcSEcCtD
Trametinib—Diarrhoea—Simvastatin—coronary artery disease	9.74e-05	0.000433	CcSEcCtD
Trametinib—Gastrointestinal disorder—Furosemide—coronary artery disease	9.73e-05	0.000432	CcSEcCtD
Trametinib—Myalgia—Ramipril—coronary artery disease	9.73e-05	0.000432	CcSEcCtD
Trametinib—Arthralgia—Ramipril—coronary artery disease	9.73e-05	0.000432	CcSEcCtD
Trametinib—Fatigue—Furosemide—coronary artery disease	9.72e-05	0.000432	CcSEcCtD
Trametinib—Body temperature increased—Telmisartan—coronary artery disease	9.71e-05	0.000431	CcSEcCtD
Trametinib—Abdominal pain—Telmisartan—coronary artery disease	9.71e-05	0.000431	CcSEcCtD
Trametinib—Vomiting—Lovastatin—coronary artery disease	9.68e-05	0.00043	CcSEcCtD
Trametinib—Dizziness—Eplerenone—coronary artery disease	9.66e-05	0.000429	CcSEcCtD
Trametinib—Rash—Clopidogrel—coronary artery disease	9.66e-05	0.000429	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	9.66e-05	0.000429	CcSEcCtD
Trametinib—Dermatitis—Clopidogrel—coronary artery disease	9.65e-05	0.000429	CcSEcCtD
Trametinib—Asthenia—Valsartan—coronary artery disease	9.65e-05	0.000429	CcSEcCtD
Trametinib—Hypertension—Timolol—coronary artery disease	9.64e-05	0.000429	CcSEcCtD
Trametinib—Constipation—Furosemide—coronary artery disease	9.64e-05	0.000428	CcSEcCtD
Trametinib—Asthenia—Olmesartan—coronary artery disease	9.6e-05	0.000427	CcSEcCtD
Trametinib—Headache—Clopidogrel—coronary artery disease	9.6e-05	0.000427	CcSEcCtD
Trametinib—Rash—Lovastatin—coronary artery disease	9.6e-05	0.000427	CcSEcCtD
Trametinib—Dermatitis—Lovastatin—coronary artery disease	9.59e-05	0.000426	CcSEcCtD
Trametinib—Anaemia—Lisinopril—coronary artery disease	9.58e-05	0.000426	CcSEcCtD
Trametinib—Headache—Lovastatin—coronary artery disease	9.53e-05	0.000424	CcSEcCtD
Trametinib—Pruritus—Valsartan—coronary artery disease	9.51e-05	0.000423	CcSEcCtD
Trametinib—Dry mouth—Ramipril—coronary artery disease	9.51e-05	0.000423	CcSEcCtD
Trametinib—Arthralgia—Timolol—coronary artery disease	9.51e-05	0.000423	CcSEcCtD
Trametinib—Myalgia—Timolol—coronary artery disease	9.51e-05	0.000423	CcSEcCtD
Trametinib—Vomiting—Ezetimibe—coronary artery disease	9.49e-05	0.000422	CcSEcCtD
Trametinib—Gastrointestinal pain—Perindopril—coronary artery disease	9.48e-05	0.000421	CcSEcCtD
Trametinib—Pruritus—Olmesartan—coronary artery disease	9.47e-05	0.000421	CcSEcCtD
Trametinib—Decreased appetite—Losartan—coronary artery disease	9.45e-05	0.00042	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.44e-05	0.00042	CcSEcCtD
Trametinib—Abdominal pain—Captopril—coronary artery disease	9.44e-05	0.000419	CcSEcCtD
Trametinib—Body temperature increased—Captopril—coronary artery disease	9.44e-05	0.000419	CcSEcCtD
Trametinib—Dizziness—Simvastatin—coronary artery disease	9.41e-05	0.000418	CcSEcCtD
Trametinib—Rash—Ezetimibe—coronary artery disease	9.41e-05	0.000418	CcSEcCtD
Trametinib—Dermatitis—Ezetimibe—coronary artery disease	9.4e-05	0.000418	CcSEcCtD
Trametinib—Asthenia—Niacin—coronary artery disease	9.38e-05	0.000417	CcSEcCtD
Trametinib—Fatigue—Losartan—coronary artery disease	9.37e-05	0.000417	CcSEcCtD
Trametinib—Headache—Ezetimibe—coronary artery disease	9.35e-05	0.000416	CcSEcCtD
Trametinib—Oedema—Ramipril—coronary artery disease	9.32e-05	0.000414	CcSEcCtD
Trametinib—Dry mouth—Timolol—coronary artery disease	9.3e-05	0.000413	CcSEcCtD
Trametinib—Constipation—Losartan—coronary artery disease	9.3e-05	0.000413	CcSEcCtD
Trametinib—Vomiting—Eplerenone—coronary artery disease	9.29e-05	0.000413	CcSEcCtD
Trametinib—Leukopenia—Lisinopril—coronary artery disease	9.27e-05	0.000412	CcSEcCtD
Trametinib—Nausea—Fenofibrate—coronary artery disease	9.26e-05	0.000411	CcSEcCtD
Trametinib—Pruritus—Niacin—coronary artery disease	9.25e-05	0.000411	CcSEcCtD
Trametinib—Asthenia—Pravastatin—coronary artery disease	9.23e-05	0.00041	CcSEcCtD
Trametinib—Gastrointestinal pain—Furosemide—coronary artery disease	9.22e-05	0.00041	CcSEcCtD
Trametinib—Rash—Eplerenone—coronary artery disease	9.21e-05	0.000409	CcSEcCtD
Trametinib—Dermatitis—Eplerenone—coronary artery disease	9.2e-05	0.000409	CcSEcCtD
Trametinib—Diarrhoea—Valsartan—coronary artery disease	9.2e-05	0.000409	CcSEcCtD
Trametinib—Abdominal pain—Perindopril—coronary artery disease	9.16e-05	0.000407	CcSEcCtD
Trametinib—Body temperature increased—Perindopril—coronary artery disease	9.16e-05	0.000407	CcSEcCtD
Trametinib—Diarrhoea—Olmesartan—coronary artery disease	9.15e-05	0.000407	CcSEcCtD
Trametinib—Headache—Eplerenone—coronary artery disease	9.15e-05	0.000407	CcSEcCtD
Trametinib—Nervous system disorder—Ramipril—coronary artery disease	9.14e-05	0.000406	CcSEcCtD
Trametinib—Thrombocytopenia—Ramipril—coronary artery disease	9.13e-05	0.000406	CcSEcCtD
Trametinib—Oedema—Timolol—coronary artery disease	9.11e-05	0.000405	CcSEcCtD
Trametinib—Pruritus—Pravastatin—coronary artery disease	9.11e-05	0.000405	CcSEcCtD
Trametinib—Nausea—Clopidogrel—coronary artery disease	9.1e-05	0.000404	CcSEcCtD
Trametinib—Skin disorder—Ramipril—coronary artery disease	9.06e-05	0.000402	CcSEcCtD
Trametinib—Infection—Timolol—coronary artery disease	9.05e-05	0.000402	CcSEcCtD
Trametinib—Vomiting—Simvastatin—coronary artery disease	9.05e-05	0.000402	CcSEcCtD
Trametinib—Cough—Lisinopril—coronary artery disease	9.04e-05	0.000402	CcSEcCtD
Trametinib—Nausea—Lovastatin—coronary artery disease	9.04e-05	0.000402	CcSEcCtD
Trametinib—Hyperhidrosis—Ramipril—coronary artery disease	9.01e-05	0.000401	CcSEcCtD
Trametinib—Rash—Simvastatin—coronary artery disease	8.98e-05	0.000399	CcSEcCtD
Trametinib—Dermatitis—Simvastatin—coronary artery disease	8.97e-05	0.000399	CcSEcCtD
Trametinib—Asthenia—Trandolapril—coronary artery disease	8.97e-05	0.000399	CcSEcCtD
Trametinib—Diarrhoea—Niacin—coronary artery disease	8.94e-05	0.000398	CcSEcCtD
Trametinib—Nervous system disorder—Timolol—coronary artery disease	8.94e-05	0.000397	CcSEcCtD
Trametinib—Asthenia—Enalapril—coronary artery disease	8.93e-05	0.000397	CcSEcCtD
Trametinib—Headache—Simvastatin—coronary artery disease	8.92e-05	0.000396	CcSEcCtD
Trametinib—Abdominal pain—Furosemide—coronary artery disease	8.91e-05	0.000396	CcSEcCtD
Trametinib—Body temperature increased—Furosemide—coronary artery disease	8.91e-05	0.000396	CcSEcCtD
Trametinib—Gastrointestinal pain—Losartan—coronary artery disease	8.89e-05	0.000395	CcSEcCtD
Trametinib—Dizziness—Valsartan—coronary artery disease	8.89e-05	0.000395	CcSEcCtD
Trametinib—Nausea—Ezetimibe—coronary artery disease	8.87e-05	0.000394	CcSEcCtD
Trametinib—Skin disorder—Timolol—coronary artery disease	8.85e-05	0.000393	CcSEcCtD
Trametinib—Dizziness—Olmesartan—coronary artery disease	8.85e-05	0.000393	CcSEcCtD
Trametinib—Pruritus—Trandolapril—coronary artery disease	8.84e-05	0.000393	CcSEcCtD
Trametinib—Myalgia—Lisinopril—coronary artery disease	8.82e-05	0.000392	CcSEcCtD
Trametinib—Arthralgia—Lisinopril—coronary artery disease	8.82e-05	0.000392	CcSEcCtD
Trametinib—Hyperhidrosis—Timolol—coronary artery disease	8.81e-05	0.000392	CcSEcCtD
Trametinib—Asthenia—Telmisartan—coronary artery disease	8.81e-05	0.000392	CcSEcCtD
Trametinib—Pruritus—Enalapril—coronary artery disease	8.81e-05	0.000391	CcSEcCtD
Trametinib—Diarrhoea—Pravastatin—coronary artery disease	8.81e-05	0.000391	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.76e-05	0.000389	CcSEcCtD
Trametinib—Pruritus—Telmisartan—coronary artery disease	8.69e-05	0.000386	CcSEcCtD
Trametinib—Nausea—Eplerenone—coronary artery disease	8.68e-05	0.000386	CcSEcCtD
Trametinib—Dizziness—Niacin—coronary artery disease	8.64e-05	0.000384	CcSEcCtD
Trametinib—Dry mouth—Lisinopril—coronary artery disease	8.63e-05	0.000383	CcSEcCtD
Trametinib—Body temperature increased—Losartan—coronary artery disease	8.6e-05	0.000382	CcSEcCtD
Trametinib—Abdominal pain—Losartan—coronary artery disease	8.6e-05	0.000382	CcSEcCtD
Trametinib—Asthenia—Captopril—coronary artery disease	8.57e-05	0.000381	CcSEcCtD
Trametinib—Diarrhoea—Trandolapril—coronary artery disease	8.55e-05	0.00038	CcSEcCtD
Trametinib—Vomiting—Valsartan—coronary artery disease	8.55e-05	0.00038	CcSEcCtD
Trametinib—Diarrhoea—Enalapril—coronary artery disease	8.52e-05	0.000379	CcSEcCtD
Trametinib—Dizziness—Pravastatin—coronary artery disease	8.51e-05	0.000378	CcSEcCtD
Trametinib—Vomiting—Olmesartan—coronary artery disease	8.51e-05	0.000378	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.49e-05	0.000378	CcSEcCtD
Trametinib—Rash—Valsartan—coronary artery disease	8.48e-05	0.000377	CcSEcCtD
Trametinib—Dermatitis—Valsartan—coronary artery disease	8.47e-05	0.000376	CcSEcCtD
Trametinib—Nausea—Simvastatin—coronary artery disease	8.46e-05	0.000376	CcSEcCtD
Trametinib—Oedema—Lisinopril—coronary artery disease	8.46e-05	0.000376	CcSEcCtD
Trametinib—Pruritus—Captopril—coronary artery disease	8.45e-05	0.000375	CcSEcCtD
Trametinib—Rash—Olmesartan—coronary artery disease	8.44e-05	0.000375	CcSEcCtD
Trametinib—Insomnia—Ramipril—coronary artery disease	8.43e-05	0.000375	CcSEcCtD
Trametinib—Dermatitis—Olmesartan—coronary artery disease	8.43e-05	0.000375	CcSEcCtD
Trametinib—Headache—Valsartan—coronary artery disease	8.42e-05	0.000374	CcSEcCtD
Trametinib—Diarrhoea—Telmisartan—coronary artery disease	8.4e-05	0.000373	CcSEcCtD
Trametinib—Infection—Lisinopril—coronary artery disease	8.4e-05	0.000373	CcSEcCtD
Trametinib—Headache—Olmesartan—coronary artery disease	8.38e-05	0.000373	CcSEcCtD
Trametinib—Asthenia—Perindopril—coronary artery disease	8.32e-05	0.00037	CcSEcCtD
Trametinib—Vomiting—Niacin—coronary artery disease	8.31e-05	0.000369	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Timolol—coronary artery disease	8.3e-05	0.000369	CcSEcCtD
Trametinib—Thrombocytopenia—Lisinopril—coronary artery disease	8.28e-05	0.000368	CcSEcCtD
Trametinib—Dizziness—Trandolapril—coronary artery disease	8.27e-05	0.000367	CcSEcCtD
Trametinib—Insomnia—Timolol—coronary artery disease	8.24e-05	0.000366	CcSEcCtD
Trametinib—Rash—Niacin—coronary artery disease	8.24e-05	0.000366	CcSEcCtD
Trametinib—Dermatitis—Niacin—coronary artery disease	8.23e-05	0.000366	CcSEcCtD
Trametinib—Dizziness—Enalapril—coronary artery disease	8.23e-05	0.000366	CcSEcCtD
Trametinib—Skin disorder—Lisinopril—coronary artery disease	8.21e-05	0.000365	CcSEcCtD
Trametinib—Pruritus—Perindopril—coronary artery disease	8.2e-05	0.000365	CcSEcCtD
Trametinib—Headache—Niacin—coronary artery disease	8.19e-05	0.000364	CcSEcCtD
Trametinib—Vomiting—Pravastatin—coronary artery disease	8.18e-05	0.000364	CcSEcCtD
Trametinib—Hyperhidrosis—Lisinopril—coronary artery disease	8.17e-05	0.000363	CcSEcCtD
Trametinib—Diarrhoea—Captopril—coronary artery disease	8.17e-05	0.000363	CcSEcCtD
Trametinib—Dizziness—Telmisartan—coronary artery disease	8.12e-05	0.000361	CcSEcCtD
Trametinib—Rash—Pravastatin—coronary artery disease	8.12e-05	0.000361	CcSEcCtD
Trametinib—Dermatitis—Pravastatin—coronary artery disease	8.11e-05	0.00036	CcSEcCtD
Trametinib—Decreased appetite—Ramipril—coronary artery disease	8.1e-05	0.00036	CcSEcCtD
Trametinib—Asthenia—Furosemide—coronary artery disease	8.09e-05	0.000359	CcSEcCtD
Trametinib—Headache—Pravastatin—coronary artery disease	8.06e-05	0.000358	CcSEcCtD
Trametinib—Gastrointestinal disorder—Ramipril—coronary artery disease	8.05e-05	0.000358	CcSEcCtD
Trametinib—Fatigue—Ramipril—coronary artery disease	8.04e-05	0.000357	CcSEcCtD
Trametinib—Nausea—Valsartan—coronary artery disease	7.99e-05	0.000355	CcSEcCtD
Trametinib—Pruritus—Furosemide—coronary artery disease	7.97e-05	0.000354	CcSEcCtD
Trametinib—Constipation—Ramipril—coronary artery disease	7.97e-05	0.000354	CcSEcCtD
Trametinib—Nausea—Olmesartan—coronary artery disease	7.95e-05	0.000353	CcSEcCtD
Trametinib—Vomiting—Trandolapril—coronary artery disease	7.95e-05	0.000353	CcSEcCtD
Trametinib—Diarrhoea—Perindopril—coronary artery disease	7.93e-05	0.000353	CcSEcCtD
Trametinib—Decreased appetite—Timolol—coronary artery disease	7.92e-05	0.000352	CcSEcCtD
Trametinib—Vomiting—Enalapril—coronary artery disease	7.91e-05	0.000352	CcSEcCtD
Trametinib—Dizziness—Captopril—coronary artery disease	7.9e-05	0.000351	CcSEcCtD
Trametinib—Rash—Trandolapril—coronary artery disease	7.88e-05	0.00035	CcSEcCtD
Trametinib—Dermatitis—Trandolapril—coronary artery disease	7.87e-05	0.00035	CcSEcCtD
Trametinib—Gastrointestinal disorder—Timolol—coronary artery disease	7.87e-05	0.00035	CcSEcCtD
Trametinib—Fatigue—Timolol—coronary artery disease	7.86e-05	0.000349	CcSEcCtD
Trametinib—Rash—Enalapril—coronary artery disease	7.85e-05	0.000349	CcSEcCtD
Trametinib—Dermatitis—Enalapril—coronary artery disease	7.84e-05	0.000349	CcSEcCtD
Trametinib—Headache—Trandolapril—coronary artery disease	7.83e-05	0.000348	CcSEcCtD
Trametinib—Vomiting—Telmisartan—coronary artery disease	7.81e-05	0.000347	CcSEcCtD
Trametinib—Asthenia—Losartan—coronary artery disease	7.8e-05	0.000347	CcSEcCtD
Trametinib—Headache—Enalapril—coronary artery disease	7.8e-05	0.000347	CcSEcCtD
Trametinib—Nausea—Niacin—coronary artery disease	7.76e-05	0.000345	CcSEcCtD
Trametinib—Rash—Telmisartan—coronary artery disease	7.74e-05	0.000344	CcSEcCtD
Trametinib—Dermatitis—Telmisartan—coronary artery disease	7.73e-05	0.000344	CcSEcCtD
Trametinib—Diarrhoea—Furosemide—coronary artery disease	7.71e-05	0.000343	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.7e-05	0.000342	CcSEcCtD
Trametinib—Pruritus—Losartan—coronary artery disease	7.69e-05	0.000342	CcSEcCtD
Trametinib—Headache—Telmisartan—coronary artery disease	7.69e-05	0.000342	CcSEcCtD
Trametinib—Dizziness—Perindopril—coronary artery disease	7.67e-05	0.000341	CcSEcCtD
Trametinib—Insomnia—Lisinopril—coronary artery disease	7.65e-05	0.00034	CcSEcCtD
Trametinib—Nausea—Pravastatin—coronary artery disease	7.65e-05	0.00034	CcSEcCtD
Trametinib—Gastrointestinal pain—Ramipril—coronary artery disease	7.62e-05	0.000339	CcSEcCtD
Trametinib—Vomiting—Captopril—coronary artery disease	7.59e-05	0.000337	CcSEcCtD
Trametinib—Rash—Captopril—coronary artery disease	7.53e-05	0.000335	CcSEcCtD
Trametinib—Dermatitis—Captopril—coronary artery disease	7.52e-05	0.000334	CcSEcCtD
Trametinib—Headache—Captopril—coronary artery disease	7.48e-05	0.000332	CcSEcCtD
Trametinib—Gastrointestinal pain—Timolol—coronary artery disease	7.45e-05	0.000331	CcSEcCtD
Trametinib—Dizziness—Furosemide—coronary artery disease	7.45e-05	0.000331	CcSEcCtD
Trametinib—Diarrhoea—Losartan—coronary artery disease	7.44e-05	0.000331	CcSEcCtD
Trametinib—Nausea—Trandolapril—coronary artery disease	7.42e-05	0.00033	CcSEcCtD
Trametinib—Nausea—Enalapril—coronary artery disease	7.39e-05	0.000329	CcSEcCtD
Trametinib—Vomiting—Perindopril—coronary artery disease	7.37e-05	0.000328	CcSEcCtD
Trametinib—Body temperature increased—Ramipril—coronary artery disease	7.37e-05	0.000328	CcSEcCtD
Trametinib—Abdominal pain—Ramipril—coronary artery disease	7.37e-05	0.000328	CcSEcCtD
Trametinib—Decreased appetite—Lisinopril—coronary artery disease	7.35e-05	0.000327	CcSEcCtD
Trametinib—Rash—Perindopril—coronary artery disease	7.31e-05	0.000325	CcSEcCtD
Trametinib—Dermatitis—Perindopril—coronary artery disease	7.3e-05	0.000325	CcSEcCtD
Trametinib—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.3e-05	0.000324	CcSEcCtD
Trametinib—Nausea—Telmisartan—coronary artery disease	7.29e-05	0.000324	CcSEcCtD
Trametinib—Fatigue—Lisinopril—coronary artery disease	7.29e-05	0.000324	CcSEcCtD
Trametinib—Headache—Perindopril—coronary artery disease	7.26e-05	0.000323	CcSEcCtD
Trametinib—Constipation—Lisinopril—coronary artery disease	7.23e-05	0.000321	CcSEcCtD
Trametinib—Body temperature increased—Timolol—coronary artery disease	7.21e-05	0.00032	CcSEcCtD
Trametinib—Abdominal pain—Timolol—coronary artery disease	7.21e-05	0.00032	CcSEcCtD
Trametinib—Dizziness—Losartan—coronary artery disease	7.19e-05	0.00032	CcSEcCtD
Trametinib—Vomiting—Furosemide—coronary artery disease	7.17e-05	0.000318	CcSEcCtD
Trametinib—Rash—Furosemide—coronary artery disease	7.11e-05	0.000316	CcSEcCtD
Trametinib—Dermatitis—Furosemide—coronary artery disease	7.1e-05	0.000315	CcSEcCtD
Trametinib—Nausea—Captopril—coronary artery disease	7.09e-05	0.000315	CcSEcCtD
Trametinib—Headache—Furosemide—coronary artery disease	7.06e-05	0.000314	CcSEcCtD
Trametinib—Gastrointestinal pain—Lisinopril—coronary artery disease	6.91e-05	0.000307	CcSEcCtD
Trametinib—Vomiting—Losartan—coronary artery disease	6.91e-05	0.000307	CcSEcCtD
Trametinib—Nausea—Perindopril—coronary artery disease	6.89e-05	0.000306	CcSEcCtD
Trametinib—Rash—Losartan—coronary artery disease	6.86e-05	0.000305	CcSEcCtD
Trametinib—Dermatitis—Losartan—coronary artery disease	6.85e-05	0.000304	CcSEcCtD
Trametinib—Headache—Losartan—coronary artery disease	6.81e-05	0.000303	CcSEcCtD
Trametinib—Nausea—Furosemide—coronary artery disease	6.69e-05	0.000297	CcSEcCtD
Trametinib—Asthenia—Ramipril—coronary artery disease	6.69e-05	0.000297	CcSEcCtD
Trametinib—Body temperature increased—Lisinopril—coronary artery disease	6.68e-05	0.000297	CcSEcCtD
Trametinib—Abdominal pain—Lisinopril—coronary artery disease	6.68e-05	0.000297	CcSEcCtD
Trametinib—Pruritus—Ramipril—coronary artery disease	6.6e-05	0.000293	CcSEcCtD
Trametinib—Asthenia—Timolol—coronary artery disease	6.54e-05	0.000291	CcSEcCtD
Trametinib—Nausea—Losartan—coronary artery disease	6.46e-05	0.000287	CcSEcCtD
Trametinib—Pruritus—Timolol—coronary artery disease	6.45e-05	0.000287	CcSEcCtD
Trametinib—Diarrhoea—Ramipril—coronary artery disease	6.38e-05	0.000284	CcSEcCtD
Trametinib—Diarrhoea—Timolol—coronary artery disease	6.24e-05	0.000277	CcSEcCtD
Trametinib—Dizziness—Ramipril—coronary artery disease	6.17e-05	0.000274	CcSEcCtD
Trametinib—Asthenia—Lisinopril—coronary artery disease	6.07e-05	0.00027	CcSEcCtD
Trametinib—Dizziness—Timolol—coronary artery disease	6.03e-05	0.000268	CcSEcCtD
Trametinib—Pruritus—Lisinopril—coronary artery disease	5.98e-05	0.000266	CcSEcCtD
Trametinib—Vomiting—Ramipril—coronary artery disease	5.93e-05	0.000263	CcSEcCtD
Trametinib—Rash—Ramipril—coronary artery disease	5.88e-05	0.000261	CcSEcCtD
Trametinib—Dermatitis—Ramipril—coronary artery disease	5.87e-05	0.000261	CcSEcCtD
Trametinib—Headache—Ramipril—coronary artery disease	5.84e-05	0.00026	CcSEcCtD
Trametinib—Vomiting—Timolol—coronary artery disease	5.8e-05	0.000258	CcSEcCtD
Trametinib—Diarrhoea—Lisinopril—coronary artery disease	5.79e-05	0.000257	CcSEcCtD
Trametinib—Rash—Timolol—coronary artery disease	5.75e-05	0.000255	CcSEcCtD
Trametinib—Dermatitis—Timolol—coronary artery disease	5.74e-05	0.000255	CcSEcCtD
Trametinib—Headache—Timolol—coronary artery disease	5.71e-05	0.000254	CcSEcCtD
Trametinib—Dizziness—Lisinopril—coronary artery disease	5.59e-05	0.000249	CcSEcCtD
Trametinib—Nausea—Ramipril—coronary artery disease	5.54e-05	0.000246	CcSEcCtD
Trametinib—Nausea—Timolol—coronary artery disease	5.41e-05	0.000241	CcSEcCtD
Trametinib—Vomiting—Lisinopril—coronary artery disease	5.38e-05	0.000239	CcSEcCtD
Trametinib—Rash—Lisinopril—coronary artery disease	5.33e-05	0.000237	CcSEcCtD
Trametinib—Dermatitis—Lisinopril—coronary artery disease	5.33e-05	0.000237	CcSEcCtD
Trametinib—Headache—Lisinopril—coronary artery disease	5.3e-05	0.000235	CcSEcCtD
Trametinib—Nausea—Lisinopril—coronary artery disease	5.02e-05	0.000223	CcSEcCtD
Trametinib—MAP2K2—Immune System—BCL2—coronary artery disease	5.28e-06	2.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RPS6KB1—coronary artery disease	5.24e-06	2.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MEF2C—coronary artery disease	5.24e-06	2.34e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.22e-06	2.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HBA1—coronary artery disease	5.21e-06	2.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2C19—coronary artery disease	5.21e-06	2.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LIPC—coronary artery disease	5.21e-06	2.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	5.21e-06	2.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF2—coronary artery disease	5.21e-06	2.32e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCD—coronary artery disease	5.21e-06	2.32e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOC3—coronary artery disease	5.18e-06	2.31e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LDLR—coronary artery disease	5.15e-06	2.3e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.15e-06	2.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLIN1—coronary artery disease	5.14e-06	2.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DLAT—coronary artery disease	5.14e-06	2.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PFKFB3—coronary artery disease	5.14e-06	2.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—COX5B—coronary artery disease	5.14e-06	2.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM2—coronary artery disease	5.14e-06	2.29e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF2—coronary artery disease	5.14e-06	2.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ITGB3—coronary artery disease	5.11e-06	2.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2A—coronary artery disease	5.1e-06	2.27e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC9A1—coronary artery disease	5.09e-06	2.27e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTT1—coronary artery disease	5.09e-06	2.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—C3—coronary artery disease	5.09e-06	2.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—coronary artery disease	5.07e-06	2.26e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCLC—coronary artery disease	5.03e-06	2.24e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CETP—coronary artery disease	5.03e-06	2.24e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—JAK2—coronary artery disease	4.99e-06	2.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL8—coronary artery disease	4.99e-06	2.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—coronary artery disease	4.97e-06	2.22e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SDC1—coronary artery disease	4.97e-06	2.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SERPINE1—coronary artery disease	4.97e-06	2.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PIK3CA—coronary artery disease	4.96e-06	2.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PPP2CA—coronary artery disease	4.96e-06	2.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—BCL2—coronary artery disease	4.94e-06	2.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—JAK2—coronary artery disease	4.93e-06	2.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—AKT1—coronary artery disease	4.91e-06	2.19e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SULT1E1—coronary artery disease	4.87e-06	2.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCD—coronary artery disease	4.87e-06	2.17e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HIF1A—coronary artery disease	4.85e-06	2.16e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AGT—coronary artery disease	4.83e-06	2.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF2—coronary artery disease	4.81e-06	2.14e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—coronary artery disease	4.77e-06	2.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—C3—coronary artery disease	4.76e-06	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—coronary artery disease	4.74e-06	2.11e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LEP—coronary artery disease	4.74e-06	2.11e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—coronary artery disease	4.74e-06	2.11e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PSMA6—coronary artery disease	4.7e-06	2.1e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PSMB5—coronary artery disease	4.7e-06	2.1e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—coronary artery disease	4.7e-06	2.09e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.69e-06	2.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOA1—coronary artery disease	4.68e-06	2.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—coronary artery disease	4.67e-06	2.08e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKR1B1—coronary artery disease	4.65e-06	2.07e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HK2—coronary artery disease	4.65e-06	2.07e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KDR—coronary artery disease	4.64e-06	2.07e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—coronary artery disease	4.64e-06	2.07e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK14—coronary artery disease	4.61e-06	2.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—JAK2—coronary artery disease	4.61e-06	2.05e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CTGF—coronary artery disease	4.59e-06	2.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—coronary artery disease	4.59e-06	2.05e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMGCR—coronary artery disease	4.55e-06	2.03e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT2—coronary artery disease	4.55e-06	2.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HIF1A—coronary artery disease	4.54e-06	2.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AGT—coronary artery disease	4.52e-06	2.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ESR1—coronary artery disease	4.52e-06	2.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—F2—coronary artery disease	4.47e-06	1.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FN1—coronary artery disease	4.47e-06	1.99e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.46e-06	1.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6ST—coronary artery disease	4.45e-06	1.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—coronary artery disease	4.43e-06	1.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LEP—coronary artery disease	4.43e-06	1.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NFKBIA—coronary artery disease	4.41e-06	1.97e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—coronary artery disease	4.39e-06	1.96e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOA1—coronary artery disease	4.38e-06	1.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LCAT—coronary artery disease	4.37e-06	1.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.37e-06	1.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—coronary artery disease	4.37e-06	1.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KDR—coronary artery disease	4.34e-06	1.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—coronary artery disease	4.34e-06	1.93e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—coronary artery disease	4.33e-06	1.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK14—coronary artery disease	4.31e-06	1.92e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA4—coronary artery disease	4.29e-06	1.91e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KIT—coronary artery disease	4.28e-06	1.91e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ESR1—coronary artery disease	4.23e-06	1.89e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLCB1—coronary artery disease	4.18e-06	1.87e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FN1—coronary artery disease	4.18e-06	1.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—F2—coronary artery disease	4.18e-06	1.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6ST—coronary artery disease	4.16e-06	1.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.14e-06	1.85e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCLM—coronary artery disease	4.14e-06	1.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NFKBIA—coronary artery disease	4.13e-06	1.84e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.1e-06	1.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GSK3B—coronary artery disease	4.1e-06	1.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CREB1—coronary artery disease	4.07e-06	1.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—POMC—coronary artery disease	4.07e-06	1.81e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCA1—coronary artery disease	4.06e-06	1.81e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—coronary artery disease	4.05e-06	1.81e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.01e-06	1.79e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.01e-06	1.79e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KIT—coronary artery disease	4e-06	1.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—coronary artery disease	3.98e-06	1.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6R—coronary artery disease	3.97e-06	1.77e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.95e-06	1.76e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT1—coronary artery disease	3.93e-06	1.75e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GGT1—coronary artery disease	3.93e-06	1.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—coronary artery disease	3.91e-06	1.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—MAPK1—coronary artery disease	3.9e-06	1.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HADH—coronary artery disease	3.9e-06	1.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.9e-06	1.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GSK3B—coronary artery disease	3.84e-06	1.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—POMC—coronary artery disease	3.81e-06	1.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CREB1—coronary artery disease	3.81e-06	1.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—coronary artery disease	3.73e-06	1.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SERPINE1—coronary artery disease	3.72e-06	1.66e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6R—coronary artery disease	3.71e-06	1.66e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA2—coronary artery disease	3.69e-06	1.65e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.69e-06	1.65e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX2—coronary artery disease	3.69e-06	1.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—coronary artery disease	3.66e-06	1.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.65e-06	1.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.65e-06	1.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX4—coronary artery disease	3.65e-06	1.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HK1—coronary artery disease	3.65e-06	1.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—MAPK1—coronary artery disease	3.64e-06	1.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HADHA—coronary artery disease	3.6e-06	1.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF2—coronary artery disease	3.6e-06	1.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.56e-06	1.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK1—coronary artery disease	3.56e-06	1.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—coronary artery disease	3.55e-06	1.58e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTP1—coronary artery disease	3.53e-06	1.57e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPA—coronary artery disease	3.52e-06	1.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	3.5e-06	1.56e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMOX1—coronary artery disease	3.48e-06	1.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SERPINE1—coronary artery disease	3.48e-06	1.55e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—JAK2—coronary artery disease	3.45e-06	1.54e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAT—coronary artery disease	3.43e-06	1.53e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.41e-06	1.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PIK3CA—coronary artery disease	3.38e-06	1.51e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA5—coronary artery disease	3.38e-06	1.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF2—coronary artery disease	3.37e-06	1.5e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—coronary artery disease	3.35e-06	1.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOB—coronary artery disease	3.33e-06	1.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK1—coronary artery disease	3.33e-06	1.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—coronary artery disease	3.32e-06	1.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—P4HB—coronary artery disease	3.31e-06	1.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MAPK1—coronary artery disease	3.29e-06	1.47e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.25e-06	1.45e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.24e-06	1.45e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—JAK2—coronary artery disease	3.23e-06	1.44e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPL—coronary artery disease	3.18e-06	1.42e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PIK3CA—coronary artery disease	3.16e-06	1.41e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL8—coronary artery disease	3.15e-06	1.4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—coronary artery disease	3.14e-06	1.4e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GPX1—coronary artery disease	3.1e-06	1.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PIK3CA—coronary artery disease	3.09e-06	1.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MAPK1—coronary artery disease	3.07e-06	1.37e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—VCAN—coronary artery disease	3.06e-06	1.37e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.04e-06	1.36e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CD36—coronary artery disease	3.02e-06	1.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CASP3—coronary artery disease	3.01e-06	1.34e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—coronary artery disease	2.99e-06	1.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPP2CA—coronary artery disease	2.99e-06	1.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DCN—coronary artery disease	2.95e-06	1.32e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL8—coronary artery disease	2.95e-06	1.31e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCND1—coronary artery disease	2.93e-06	1.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PIK3CA—coronary artery disease	2.89e-06	1.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.87e-06	1.28e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—coronary artery disease	2.87e-06	1.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PIK3CA—coronary artery disease	2.85e-06	1.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—coronary artery disease	2.85e-06	1.27e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CASP3—coronary artery disease	2.82e-06	1.26e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—coronary artery disease	2.8e-06	1.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.8e-06	1.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.8e-06	1.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HBA1—coronary artery disease	2.8e-06	1.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LIPC—coronary artery disease	2.8e-06	1.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOC3—coronary artery disease	2.78e-06	1.24e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LDLR—coronary artery disease	2.76e-06	1.23e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—coronary artery disease	2.76e-06	1.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCND1—coronary artery disease	2.74e-06	1.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—coronary artery disease	2.74e-06	1.22e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.73e-06	1.22e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.73e-06	1.22e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AGT—coronary artery disease	2.72e-06	1.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCLC—coronary artery disease	2.7e-06	1.2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CETP—coronary artery disease	2.7e-06	1.2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SDC1—coronary artery disease	2.67e-06	1.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PIK3CA—coronary artery disease	2.67e-06	1.19e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—coronary artery disease	2.67e-06	1.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—coronary artery disease	2.66e-06	1.19e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOA1—coronary artery disease	2.64e-06	1.18e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—coronary artery disease	2.58e-06	1.15e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—coronary artery disease	2.56e-06	1.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—coronary artery disease	2.56e-06	1.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—coronary artery disease	2.53e-06	1.13e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.52e-06	1.13e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—coronary artery disease	2.52e-06	1.13e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.52e-06	1.12e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.52e-06	1.12e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CTGF—coronary artery disease	2.46e-06	1.1e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.44e-06	1.09e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT2—coronary artery disease	2.44e-06	1.09e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—coronary artery disease	2.39e-06	1.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—coronary artery disease	2.36e-06	1.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—coronary artery disease	2.36e-06	1.05e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—coronary artery disease	2.35e-06	1.05e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—coronary artery disease	2.33e-06	1.04e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—coronary artery disease	2.32e-06	1.04e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK1—coronary artery disease	2.3e-06	1.03e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—POMC—coronary artery disease	2.29e-06	1.02e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.25e-06	1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—coronary artery disease	2.2e-06	9.79e-06	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—coronary artery disease	2.18e-06	9.72e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.18e-06	9.71e-06	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK1—coronary artery disease	2.15e-06	9.6e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GGT1—coronary artery disease	2.11e-06	9.4e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT1—coronary artery disease	2.11e-06	9.4e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—coronary artery disease	2.09e-06	9.31e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—coronary artery disease	2e-06	8.91e-06	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CA—coronary artery disease	2e-06	8.9e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.89e-06	8.44e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.88e-06	8.36e-06	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CA—coronary artery disease	1.87e-06	8.33e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.87e-06	8.33e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAT—coronary artery disease	1.84e-06	8.22e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.83e-06	8.15e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOB—coronary artery disease	1.79e-06	7.98e-06	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—coronary artery disease	1.77e-06	7.88e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.74e-06	7.76e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPL—coronary artery disease	1.71e-06	7.62e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX1—coronary artery disease	1.67e-06	7.43e-06	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—coronary artery disease	1.65e-06	7.38e-06	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—coronary artery disease	1.63e-06	7.27e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CD36—coronary artery disease	1.62e-06	7.24e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.6e-06	7.15e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.54e-06	6.86e-06	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—coronary artery disease	1.53e-06	6.81e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AGT—coronary artery disease	1.46e-06	6.52e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—coronary artery disease	1.43e-06	6.38e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA1—coronary artery disease	1.42e-06	6.31e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—coronary artery disease	1.25e-06	5.56e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—POMC—coronary artery disease	1.23e-06	5.48e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.12e-06	5.01e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—coronary artery disease	1.12e-06	5e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—coronary artery disease	1.07e-06	4.78e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—coronary artery disease	9.81e-07	4.37e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—coronary artery disease	9.19e-07	4.1e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.04e-07	2.69e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—coronary artery disease	4.93e-07	2.2e-06	CbGpPWpGaD
